All News

New anaphylaxis guidance shifts care toward rapid epinephrine, fewer steroids and antihistamines, and smarter ED decisions for children and adults.

Checking eGFR alone may miss early kidney stress and cardiovascular risk, Payal Kohli, MD, underscores.

New anaphylaxis guidance urges early recognition, epinephrine-first treatment, and smarter referrals.

In 142 000 adults, adding Galleri to standard screening reduced stage IV diagnoses over time in a prespecified group of 12 cancers, according to new data.

SMART trial finds clesrovimab protects high-risk children in a second RSV season, with consistent safety and fewer RSV-related hospitalizations.

Phase 3 data from KALOS and LOGOS trial support triple therapy in uncontrolled asthma, for both adolescents and adults.

A new study with infants reveals that those from vegetarian households follow growth trajectories nearly identical to their omnivorous peers by the age of 2.

Real-world data show GSK’s Arexvy is linked to 75.6% lower hospitalization risk in adults ≥60, with reduced CV events and COPD exacerbations.

Data show 44-week durable clinical remission in ulcerative colitis and endoscopic response in Crohn disease with duvakitug, a TL1A-targeting monoclonal antibody now in phase 3 trials.

ACP’s Carney urges primary care physicians to drop “provider,” saying American College of Physicians sees it eroding trust, ethics, and physician identity.

New phase 3 data show single-inhaler triple therapy boosts FEV₁ and cuts severe asthma attacks for patients uncontrolled on ICS–LABA.

New 2026 data link a usual source of primary care to 20% fewer hospitalizations and 54% lower total costs in adults with chronic disease.

Prenatal aspirin lowers severe preeclampsia 29% in high-risk pregnant patients; cardiology-driven prevention proves safe with direct dispensing.

FDA updates menopause hormone therapy labels, dropping boxed warning claims on heart disease, breast cancer, and dementia after evidence review.

Data from a new meta-analysis shows weight loss therapies were associated with clinically and statistically significant improvements in psoriasis severity. Study investigators sheds light.

Cardiologist Payal Kohli, MD, discusses why relying on eGFR alone may miss early kidney and cardiovascular risk.

Study finds many Medicaid-enrolled doctors see zero patients, worsening access and overloading others—especially in psychiatry and primary care.

Calling physicians “providers” undermines ethics and professionalism, an American College of Physicians position paper argues.